- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- May 2022
- 35 Pages
Global
From €1820EUR$2,000USD£1,560GBP
Endocarditis is a type of cardiovascular disease caused by an infection of the inner lining of the heart. Endocarditis drugs are used to treat this condition and can be divided into two categories: antibiotics and antifungal medications. Antibiotics are used to treat bacterial infections, while antifungal medications are used to treat fungal infections. These drugs are typically administered intravenously or orally, depending on the severity of the infection.
Endocarditis drugs are used to reduce the risk of complications associated with the disease, such as heart valve damage, stroke, and heart failure. They can also help to reduce the risk of recurrence of the infection.
Some of the companies in the endocarditis drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the development, manufacture, and marketing of endocarditis drugs. Show Less Read more